Answers are grounded in this paper and cite their sources.
Epidemiological studies in the 1960's first identified hypertension as a health problem for children & established an incidence that was higher than previously suspected. The first step in treatment of children with hypertension is modification of life style with emphasis on weight loss (70% are obese), decreased dietary Na intake and increased exercise. Nonetheless, many children fail to normalize BP's on these regimens and are candidates for pharmacological therapy. The best pharmacologic approach is to use the fewest well-studied drugs in the lowest effective dose; the optimal regimen is a single agent taken once daily without adverse side effects. One hundred and forty-five (145) children meeting the inclusion criteria were screened for the study; to qualify for randomization, systolic &/or diastolic BP had to be >95th percentile for age and height. One hundred and ten (110) patients met the criteria and were blindly randomized to placebo, HCTZ 6.25mg or Ziac (2.5/6.25mg). Patients were titrated so that either BP was <90th percentile for age and height, or the maximal dose of drug was administered. One hundred and three (103) patients completed all phases of the study. For purposed of analysis, patients were separated into 2 groups: 6–12 years of age (Group I) and 13–17 years of age (Group II). Preliminary demographic characteristics are shown in the table below. Final data will be available at the time of presentation. The data regarding efficacy is being analyzed by age and by dose of drug to attain goal BP and will be presented. A preliminary review of the blinded data failed to reveal any serious adverse side effects.
No takes yet. Share an insight, caveat, or question.
R. J. Cunningham (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: